Trial · NCT01811459
Registered outcomes17
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 17 of 17
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Time to first resolution of delirium | 21 days | Confirmed by clinical evaluation of a psychiatrist |
| Secondary | Days in delirium during the study | 21 days | From log |
| Secondary | Duration of delirium | 21 days | From log |
| Secondary | Severity of delirium (highest Nu-DESC score, mean episode Nu-DESC score) | 21 days | Nursing evaluation every 8 hours- shift |
| Secondary | ICU and hospital mortality | 21 days | From the chart |
| Secondary | ICU and hospital length of stay | 21 days | From the chart |
| Secondary | Length of mechanical ventilation | 21 days | From daily clinical évaluation |
| Secondary | Time spent deeply sedated (RASS <3) | 21 days | From chart |
| Secondary | Episodes of subject-initiated device removal | 21 days | From daily clinical évaluation |
| Secondary | Use of haloperidol therapy (including total dose in haloperidol equivalents during the study, number of doses, number of days of therapy, use of rescue IV haloperidol) | 21 days | From long |
| Secondary | Average daily and maximum total antipsychotic drug dose in haloperidol equivalents | 21 days | From long |
| Secondary | Duration of study drug administration | 21 days | From log |
| Secondary | Use of benzodiazepines | 21 days | All benzodiazepines received in lorazepam equivalent |
| Secondary | Use of opioids | 21 days | All opioids received in morphine équivalent |
| Secondary | QTc prolongation | 21 days | From EKG recording |
| Secondary | Extrapyramidal symptoms | 21 days | Daily clinical evaluation |
| Secondary | Neuroleptic malignant syndrome | 21 days | Daily clinical evaluation |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01811459/registered